Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
enVVeno Medical Corporation Logo
enVVeno Medical Corporation Growth Score
92
CB Rank
78146
Heat Score
57
Hancock Jaffe Laboratories develops bioprosthetic devices for cardiovascular surgeries.
Founded
obfuscation
PublicPost-IPO Equity Irvine, California, United States11-50 envveno.com/
Biotechnology
Clinical Trials
Health Care
Life Science
Manufacturing
Medical Device
Overview

enVVeno Medical Corporation
Total Funding
obfuscation
Growth Score
92
Heat Score
57

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score92
11 pts
in past quarter
Heat Score 57
16 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About enVVeno Medical Corporation

CB Rank
78146
Hancock Jaffe Laboratories develops bioprosthetic devices for cardiovascular surgeries.
Founded
obfuscation
PublicPost-IPO Equity Irvine, California, United States11-50 envveno.com/
Biotechnology
Clinical Trials
Health Care
Life Science
Manufacturing
Medical Device

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Hancock Jaffe Laboratories, Inc.
Also Known As Hancock Jaffe Laboratories
Operating Status Active
Stock Symbol  NASDAQ:NVNO
Company Type For Profit
Founders  Norman Jaffe
About the Company

Hancock Jaffe Laboratories develops life-enhancing bioprosthetic devices and technologies intended to achieve unparalleled outcomes for patients with debilitating cardiovascular diseases. Each device is designed to allow vascular and cardiothoracic surgeons to achieve maximum effectiveness while greatly reducing the time and complexity of current

procedures in concert with a commitment to efficient health care delivery.

Founded in 1987 by Norman Jaffe, Hancock Jaffe Laboratories is headquartered in Irvine, California.

Phone Number 949-261-2900
Predictions & Insights

Growth Insight

See this Growth Insight
enVVeno Medical Corporation is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

VenoValve®
A surgical venous valve replacement device designed to treat Chronic Venous Insufficiency (CVI) in the deep veins of the leg.
enVVe®
An investigational medical device under development for venous valve replacement, intended to treat venous disease.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - enVVeno Medical Corporation Logo
Post-IPO Equity - enVVeno Medical Corporation
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - enVVeno Medical Corporation Logo
Post-IPO Equity - enVVeno Medical Corporation
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - enVVeno Medical Corporation Logo
Post-IPO Equity - enVVeno Medical Corporation
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - enVVeno Medical Corporation Logo
Post-IPO Equity - enVVeno Medical Corporation
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - enVVeno Medical Corporation Logo
Post-IPO Equity - enVVeno Medical Corporation
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - enVVeno Medical Corporation Logo
Post-IPO Equity - enVVeno Medical Corporation
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - enVVeno Medical Corporation Logo
Post-IPO Equity - enVVeno Medical Corporation
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - enVVeno Medical Corporation Logo
Post-IPO Equity - enVVeno Medical Corporation
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - enVVeno Medical Corporation Logo
Post-IPO Equity - enVVeno Medical Corporation
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - enVVeno Medical Corporation Logo
Post-IPO Equity - enVVeno Medical Corporation
—
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 7 Board Members and Advisors 1 Contacts 29

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

2,675
482.79%
 in past month

IT Spend

$846.9KThis year, enVVeno Medical Corporation is projected to spend $846.9K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Google (GOOG) Logo
Google (GOOG)
73

Active Website Tech Count

3enVVeno Medical Corporation is actively using 3 technologies for its website, according to BuiltWith. These include Euro and  CommonCrawl Top 10m.

Total IP

4The intellectual property of enVVeno Medical Corporation includes 4 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is enVVeno Medical Corporation's headquarters? enVVeno Medical Corporation is located in Irvine, California, United States.Who invested in enVVeno Medical Corporation? enVVeno Medical Corporation has 5 investors including Nantahala Capital Management and  Kingdon Capital.When was the last funding round for enVVeno Medical Corporation? enVVeno Medical Corporation closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are enVVeno Medical Corporation's competitors? Alternatives and possible competitors to enVVeno Medical Corporation may include Venture Med Group, Shape Memory Medical, and  Nobles Medical Technologies.How much funding has enVVeno Medical Corporation raised to date? enVVeno Medical Corporation has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|